CHRISTY FRY: Open Payments
NPI 1568464162 · CAMP HILL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 95 payments from 15 companies in 2025. Trend: 2023 $814 · 2024 $1,247 · 2025 $2,237
Food & beverage: $1,928Consulting: $225Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $660 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $343 |
| Madrigal Pharmaceuticals | 7 | $235 |
| Celltrion USA Inc. | 11 | $204 |
| GENZYME CORPORATION | 5 | $164 |
| Ardelyx, Inc. | 3 | $127 |
| Janssen Biotech, Inc. | 3 | $119 |
| PFIZER INC. | 4 | $71 |
| Novo Nordisk Inc | 4 | $71 |
| Janssen Scientific Affairs, LLC | 1 | $70 |
Products named: XIFAXAN, RINVOQ, REZDIFFRA, DUPIXENT, VEGZELMA, TREMFYA, SKYRIZI, IBSRELA.
Industry payments across PA — which companies pay providers there.
